Accesscr Pty Ltd

Status: Registered
Australian Company Number: 126687410
Australian Business Number: 90126687410
Registration date: 2007-07-24
Type: Australian proprietary company
Class: Limited by Shares
Subclass: Proprietary other
last updated


Accesscr Pty Ltd is a limited by shares, Australian proprietary company. This corporation was registered on 2007-07-24 and was issued with the 126687410 ACN. Its Australian Business Number is 90126687410. Since 2014-09-13, the company is headquartered in NSW, post code 2122. The previous headquarters were located in NSW 2122 (from 2010-10-29 to 2014-09-13), NSW 2061 (from 2008-07-23 to 2010-10-29), and NSW 2061 (from 2007-07-25 to 2008-07-23). Accesscr Pty Ltd was registered for the GST on 2007-07-25. The company has also used 1 business name, namely Research 4 Me from 2017-01-13. The above data comes from the ABN database which was updated on 2017-01-13.


Details for ABN 90126687410

Type: Australian Private Company

ABN Status

Status From To
Active 2007-07-25 current

Main Name

Name From To
Accesscr Pty Ltd 2007-07-25 current

Business Names

Name From To
Research 4 Me 2017-01-13 current

Main Location

Location From To
NSW 2122 2014-09-13 current
NSW 2122 2010-10-29 2014-09-13
NSW 2061 2008-07-23 2010-10-29
NSW 2061 2007-07-25 2008-07-23

Goods & Services Tax (GST)

Status From To
Registered 2007-07-25 current


Find company

NSW 2122 Location

2018 © - ABN Lookup, ACN, ABR, ABN Search. All rights reserved.
Contact us:
Terms of Use and Privacy Policy

Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2018 (, and, ©Intellectual Property Government Open Data 2018, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.